INSR overexpression, which occurs in human breast cancer and other epithelial tumors, independently of ER status, remarkably increases the response to circulating insulin, especially when the hormone is abnormally high, as in obesity and T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.